高血壓 高尿酸 慢性腎病 胰島素 https://2019medicinenote.blogspot.com/2019/12/blog-post_57.html . 糖尿病相關筆記~目錄 https://2019medicinenote.blogspot.com/2020/01/blog-post_4.html

2020年4月27日 星期一

野外與登山醫學----21---WMS 2019 update HAPE PREVENTION Nifedipine 21

Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness: 2019 Update
統一名詞翻譯
AMS 急性高山病
HACE 高海拔腦水腫
HAPE 高海拔肺水腫
acute altitude illness 急性高海拔疾病

Nifedipine
A single, randomized, placebo-controlled study83 and extensive clinical experience have established a role for nifedipine in HAPE prevention in susceptible individuals. The recommended dose is 30 mg of the extended-release preparation administered every 12 h. Hypotension was not noted in the study83 and is generally not a concern with the extended-release version of the medication but may occur in a limited number of individuals. Recommendation. Nifedipine is recommended for HAPE prevention in HAPE-susceptible people. Recommendation Grade: 1B

沒有留言:

張貼留言

內科學誌2020-糖化白蛋白於糖尿病患者之臨床應用-高雄長庚內分泌暨新陳代謝科

2026-10-02 09:18AM 這篇是2020年刊登於內科學誌的. 糖化白蛋白於糖尿病患者之臨床應用 -高雄長庚內分泌暨新陳代謝科-楊逸亭 沈峰志 陳榮福 摘要 台灣健保於 2017 年開始給付糖化白蛋白 (glycated albumin, GA) 於特定族群做為血糖監測...